Cargando…

Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment

BACKGROUND: The high mobility group box 1 (HMGB1) protein mediates the cardiomyocyte–cardiac fibroblast interaction that contributes to induction of myocardial fibrosis in diabetes mellitus (DM). In the present study, we aim to investigate the intracellular signaling pathway that leads to cardiomyoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jia, Liu, Qian, Tang, Han, Tao, Aibin, Wang, Hao, Kao, Raymond, Rui, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348356/
https://www.ncbi.nlm.nih.gov/pubmed/27821807
http://dx.doi.org/10.18632/oncotarget.13096
_version_ 1782514209294123008
author Song, Jia
Liu, Qian
Tang, Han
Tao, Aibin
Wang, Hao
Kao, Raymond
Rui, Tao
author_facet Song, Jia
Liu, Qian
Tang, Han
Tao, Aibin
Wang, Hao
Kao, Raymond
Rui, Tao
author_sort Song, Jia
collection PubMed
description BACKGROUND: The high mobility group box 1 (HMGB1) protein mediates the cardiomyocyte–cardiac fibroblast interaction that contributes to induction of myocardial fibrosis in diabetes mellitus (DM). In the present study, we aim to investigate the intracellular signaling pathway that leads to cardiomyocyte HMGB1 expression under a diabetic environment. RESULTS: HMGB1 expression is increased in high concentration of glucose (HG)-conditioned cardiomyocytes. Challenging cardiomyocytes with HG also increased PI3Kγ and Akt phosphorylation. Inhibition of PI3Kγ (CRISPR/Cas9 knockout plasmid or AS605240) prevented HG-induced Akt phosphorylation and HMGB1 expression by the cardiomyocytes. In addition, inhibition of Akt (Akt1/2/3 siRNA or A6730) attenuated HG-induced HMGB1 production. Finally, challenging cardiomyocytes with HG resulted in increased reactive oxygen species (ROS) production. Treatment of cardiomyocytes with an antioxidant (Mitotempo) abolished HG-induced PI3Kγ and Akt activation, as well as HMGB1 production. MATERIALS AND METHODS: Isolated rat cardiomyocytes were cultured with a high concentration of glucose. Cardiomyocyte phosphatidylinositol 3-kinase gamma (PI3Kγ) and Akt activation were determined by Western blot. Cardiomyocyte HMGB1 production was evaluated with Western blot and enzyme-linked immunosorbent assay (ELISA), while cardiomyocyte oxidative stress was determined with a DCFDA fluorescence probe. CONCLUSIONS: Our results suggest that the cardiomyocytes incur an oxidative stress under diabetic condition, which subsequently activates the PI3Kγ/Akt cell-signaling pathway and further increases HMGB1 expression.
format Online
Article
Text
id pubmed-5348356
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53483562017-03-31 Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment Song, Jia Liu, Qian Tang, Han Tao, Aibin Wang, Hao Kao, Raymond Rui, Tao Oncotarget Research Paper BACKGROUND: The high mobility group box 1 (HMGB1) protein mediates the cardiomyocyte–cardiac fibroblast interaction that contributes to induction of myocardial fibrosis in diabetes mellitus (DM). In the present study, we aim to investigate the intracellular signaling pathway that leads to cardiomyocyte HMGB1 expression under a diabetic environment. RESULTS: HMGB1 expression is increased in high concentration of glucose (HG)-conditioned cardiomyocytes. Challenging cardiomyocytes with HG also increased PI3Kγ and Akt phosphorylation. Inhibition of PI3Kγ (CRISPR/Cas9 knockout plasmid or AS605240) prevented HG-induced Akt phosphorylation and HMGB1 expression by the cardiomyocytes. In addition, inhibition of Akt (Akt1/2/3 siRNA or A6730) attenuated HG-induced HMGB1 production. Finally, challenging cardiomyocytes with HG resulted in increased reactive oxygen species (ROS) production. Treatment of cardiomyocytes with an antioxidant (Mitotempo) abolished HG-induced PI3Kγ and Akt activation, as well as HMGB1 production. MATERIALS AND METHODS: Isolated rat cardiomyocytes were cultured with a high concentration of glucose. Cardiomyocyte phosphatidylinositol 3-kinase gamma (PI3Kγ) and Akt activation were determined by Western blot. Cardiomyocyte HMGB1 production was evaluated with Western blot and enzyme-linked immunosorbent assay (ELISA), while cardiomyocyte oxidative stress was determined with a DCFDA fluorescence probe. CONCLUSIONS: Our results suggest that the cardiomyocytes incur an oxidative stress under diabetic condition, which subsequently activates the PI3Kγ/Akt cell-signaling pathway and further increases HMGB1 expression. Impact Journals LLC 2016-11-04 /pmc/articles/PMC5348356/ /pubmed/27821807 http://dx.doi.org/10.18632/oncotarget.13096 Text en Copyright: © 2016 Song et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Song, Jia
Liu, Qian
Tang, Han
Tao, Aibin
Wang, Hao
Kao, Raymond
Rui, Tao
Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment
title Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment
title_full Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment
title_fullStr Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment
title_full_unstemmed Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment
title_short Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment
title_sort activation of pi3kγ/akt pathway increases cardiomyocyte hmgb1 expression in diabetic environment
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348356/
https://www.ncbi.nlm.nih.gov/pubmed/27821807
http://dx.doi.org/10.18632/oncotarget.13096
work_keys_str_mv AT songjia activationofpi3kgaktpathwayincreasescardiomyocytehmgb1expressionindiabeticenvironment
AT liuqian activationofpi3kgaktpathwayincreasescardiomyocytehmgb1expressionindiabeticenvironment
AT tanghan activationofpi3kgaktpathwayincreasescardiomyocytehmgb1expressionindiabeticenvironment
AT taoaibin activationofpi3kgaktpathwayincreasescardiomyocytehmgb1expressionindiabeticenvironment
AT wanghao activationofpi3kgaktpathwayincreasescardiomyocytehmgb1expressionindiabeticenvironment
AT kaoraymond activationofpi3kgaktpathwayincreasescardiomyocytehmgb1expressionindiabeticenvironment
AT ruitao activationofpi3kgaktpathwayincreasescardiomyocytehmgb1expressionindiabeticenvironment